Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 19 Neoplasm Metastasis 6 Neoplasms 4 Carcinoma, Squamous Cell 4 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Brain Neoplasms 3 Recurrence 2 Head and Neck Neoplasms 2 Glioblastoma 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Skin Squamous Cell Cancer 1 Rare Tumor 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 NSCLC 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1

Interventions

Paclitaxel 9 apatinib 8 Capecitabine 7 Oxaliplatin 6 Cisplatin 5 camrelizumab 4 S 1 (combination) 4 Fluorouracil 3 Docetaxel 3 130-nm albumin-bound paclitaxel 3 titanium silicide 2 Leucovorin 2 vorolanib 1 trifluridine tipiracil drug combination 1 tipiracil 1 spartalizumab 1 rucaparib 1 relatlimab 1 raltitrexed 1 pazopanib 1 olaparib 1 lobaplatin 1 linrodostat 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 Trifluridine 1 Sunitinib 1 SHR-1701 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Gastric Cancer × dacomitinib × Clear all

NCT01152853 2015-11-20

PF299804-AGC

Seoul National University Hospital

Phase 2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡